Background: CD4 + lymphocyte count examination is not readily available, thus simple markers are required especially in regions with limited resources. This study
Introduction
Human Immunodeficiency Virus (HIV) infection remains globally problematic let alone in region where resources are limited like Indonesia. Reports by UNAIDS in 2013 stated that there were 2.3 million new cases worldwide. Although the total of new cases is reduced by 33% compared to the incidence in year 2001, the number of people living with HIV/AIDS is relatively increase due to decreased mortality rate [1] . According to Indonesian Health Ministry, until March 2014 there were 134,042 HIV cases, 54,231 AIDS cases, and 9,615 deaths in Indonesia [2] .
Immune status of HIV patients may be assessed by absolute count of CD4 + lymphocyte which is the standard method to assess and determine the degree of immunodeficiency. WHO classified immunological status into four categories to assess the degree of immunodeficiency. Severe immunodeficiency is defined as CD4 + lymphocyte <200 cells/mm 3 . Probability of progression to AIDS stage without ARV treatment is increase along with immunodeficiency stage. Opportunistic infections and other HIV related conditions are increase significantly in CD4 + lymphocyte count < 200 cells/mm 3 [3] . Assessment of CD4 + lymphocyte count and viral load-gold standards before initiating ARV treatment-requires expensive equipments and well trained Diagnostic value of body mass index … 3 technicians, and is not readily available in some countries, some regions in Indonesia as well. Simple marker is required to guide ARV initiation in regions with limited resources where CD4 + lymphocyte count and viral load examinations are not available.
BMI is simple and frequently used to assess nutritional status. BMI is also associated with survival in HIV infection because wasting syndrome is one of AIDS defining illness. Rapid decrease of BMI within six months before AIDS symptoms appear is quite sensitive, although the sensitivity is only 33%. BMI is potential to guide ARV treatment initiation in countries with limited resources because it is very easy to do [4] .
According to guideline from Indonesian Health Ministry and WHO [6] , in the settings where CD4 + lymphocyte examination is not available, ARV treatment may be given in patients with TLC <1200 cells/mm 3 . Several studies indicated that there was good correlation between TLC and CD4 + lymphocyte [7, 8] . Predicting CD4 + lymphocyte count by using TLC has limited value particularly in determining cut off point of TLC to assess severe immunodeficiency which may affect sensitivity and specificity.
Anemia is the most frequent complication found in HIV patients, accounts for 20-80%. 9 HIV infections may result in anemia through several mechanisms. Mechanism responsible for decreased hemoglobin level and decreased CD4 + lymphocyte count in HIV infected patients is almost similar-through apoptosis of erithroid progenitor cells [10, 11] and apoptosis of CD4 + lymphocyte [12, 13] . This mechanism may explain the correlation between decreased hemoglobin level and decreased CD4 + lymphocyte count.
This study was aimed to determine the diagnostic value of combination of BMI, TLC, and hemoglobin level to predict severe immunodeficiency (CD4 + lymphocyte count <200 cells/mm 3 ) in HIV infected patients pre-ARV treatment. This combination may be applied to detect/screen patients with severe immunodeficiency and to guide ARV treatment initiation in regions with limited resources.
Methods
This is a diagnostic test to determine diagnostic accuracy of combination of BMI, TLC, and hemoglobin level in predicting severe immunodeficiency in infected HIV patients. Samples were enrolled consecutively from HIV/AIDS patients undergoing treatment in VCT ambulatory clinic and Internal Medicine wards of Sanglah General Hospital Bali-Indonesia from October to December 2012.
Inclusion criteria for this study were: HIV infected patients (age 15-60 year old), ARV-naïve and opportunistic infections treatment/prophylaxis-naïve, and normochromic-normocyter erythrocyte. While patients with acute or chronic bleeding, history of blood transfusion, autoimmune hemolytic anemia, malignancy, chronic infection and inflammation such as osteomyelitis, SLE, and rheumatoid arthritis, tumor and primary infection of bone marrow, chronic kidney disease, and pregnancy were all excluded.
Collected data were analyzed descriptively. Kolmogorov-Smirnov was used to assess data normality. Receiver operator characteristic (ROC) was used to determine cut-off point for BMI and hemoglobin level in predicting severe immunodeficiency; while for TLC cut-off point <1200 cells/mm 3 was used to predict severe immunodeficiency according to WHO crieria. 6 Using stratified multivariate analysis, diagnostic accuracy of combination of BMI, TLC, and hemoglobin level in predicting severe immunodeficiency was tested.
Results
Out of 110 samples enrolled in this study, 69 (62.7%) were male and 41 (37.3%) were female. Most frequent opportunistic infections (OI) found were wasting syndrome 67 (60.9%) and subjects were at stage 4 mostly 75 (68.2%). Distribution of age, height, weight, and body mass index (BMI) were not normal. Complete data is presented in Table 1 . (Table 2) . Correlation between BMI, TLC, hemoglobin level and CD4 + lymphocyte count is presented by scatter plot graphics where linear correlation was seen ( Figure  1 ). By Spearman's correlation test, we found significant positive moderate positive correlation between BMI and CD4 + lymphocyte count (r = 0.408; p<.001) and strong positive correlation between TLC and CD4 + lymphocyte count (r = 0.646; p<.001), and TLC and hemoglobin level (r = 0.683; p<.001), respectively. To determine cut-off point for BMI and hemoglobin level in predicting severe immunodeficiency (CD4 + lymphocyte count <200 cells/mm 3 ), ROC method was used. Because BMI and hemoglobin level would be used to screen patients with severe immunodeficiency, cut-off point with high sensitivity and moderate specificity was chosen. By ROC, we found cut-off point for BMI was <18.5 kg/m 2 (sensitivity 81.0% and specificity 50.6%). For hemoglobin level, we chose cut-off point <12.2 gr/dl (sensitivity 100% and specificity 80.4%) for male, while for female cut-off point for hemoglobin level was <11.2 gr/dl (sensitivity 87.5% and specificity 54.5%). Logistic regression was used to do stratified multivariate analysis. Diagnostic accuracy of BMI is shown by area under curve (AUC) in ROC curve. Base on ROC, we found diagnostic accuracy for BMI to predict severe immunodeficiency was 62.5% (95% CI 52.9 -77.5%; p <.031 ( Figure 2 , Table 3 ). To determine diagnostic accuracy for combination of BMI and TLC, we performed the same procedure by adding TLC variable into the analysis. Results are presented in Figure 3 and Table 4 . Diagnostic accuracy was increased by combining BMI with TLC, from 65.2% to 81.8%. Using the same procedure by adding hemoglobin variable, we found increased diagnostic accuracy for combination of BMI, TLC and hemoglobin level from 81.8% to 90.3% (Figure 4 , Table 5 ). 
Discussion
This study indicated that there were positive correlation between BMI, TLC, hemoglobin level and CD4 + lymphocyte count. Likewise CD4 + lymphocyte count, decrease of BMI, TLC, and hemoglobin level represent disease progression [4, 14, 15] . These three markers are very potential to predict severe immunodeficiency and to guide ARV treatment initiation.
By ROC method, we found cut-off point for BMI to predict severe immunodeficiency was 18.5 kg/m 2 . Studies in other countries also demonstrated similar cut-off point. Study by Castetbon et al. suggested that mortality rate was increased in patients with baseline BMI <18.5 kg/m 2 in multiracial cohort. BMI <18.5 kg/m 2 is consistently and strongly associated with increased disease progression and is also the indicator to initiate ARV treatment [16] .
According to WHO criteria 6 , cut-off point for TLC <1200 cells/mm 3 was used to predict severe immunodeficiency. Several large studies demonstrated that TLC <1200 cells/mm 3 was associated with rapid disease progression and increased mortality rate, therefore, ARV treatment should be initiated accordingly [17] .
In this study, cut-off point for hemoglobin level to predict severe immunodeficiency in male was <12.2 gr/dl (sensitivity 100 % and specificity 80.4%), and <11.2 gr/dL in female (sensitivity 87.5% and specificity 54.5%). Study by Costello et al in Thailand with 839 subjects found quite similar cut-off point to predict CD4 + lymphocyte count <200 cells/mm 3 i.e. hemoglobin level <12 gr/dl in male (sensitivity 96.4% and specificity 20.9%) while in female, cut-off point for hemoglobin level was <11 gr/dl (sensitivity 85.5% and specificity 25.0%) [18] . Study by Spacek et al involving 3,269 subjects in US found higher cut-off point for hemoglobin level, <13 gr/dl in male and <11.8 gr/dl in female, to predict CD4 + lymphocyte count <200 cells/mm 3 [19] . This showed different cut-off point in different areas and also different sensitivity and specificity.
Based on ROC curve, diagnostic accuracy of combination for BMI, TLC, and hemoglobin level shown by AUC value was 90.3%. Statistically, AUC value 90.3% is considered strong, suggesting that if combination of BMI, TLC and hemoglobin level is used to diagnose whether severe immunodeficiency is present or absent in 100 patients, the diagnosis will be correct in 90 patients [20] . This value is higher than AUC value for BMI (65.2%) alone or in combination with TLC (81.8%). Addition of this diagnostic accuracy is significant, thus combination of BMI, TLC, and hemoglobin level is recommended to be used to diagnose severe immunodeficiency in HIV infection where testing CD4 + is not available. To detect and screen patients with severe immunodeficiency who immediately need ARV treatment initiation, high sensitivity examination is required.
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Examination with high sensitivity will decrease risk for false negative results, therefore more patients will be detected [21] . By combining BMI, TLC and hemoglobin levels, we reached sensitivity 83.1% and specificity 90.5%.
Spacek et al found sensitivity of TLC <1200 cells/mm 3 to predict CD4 + lymphocyte count <200 cells/mm 3 was 70.4% and specificity 81.8%. By combining TLC <1200 cells/mm 3 and hemoglobin level <12 gr/dl in male or female, sensitivity increased to 79.4% and specificity 77.5%. 19 Other studies also suggested that determination of cut-off point for TLC and hemoglobin level based on local data was more sensitive in predicting CD4 + lymphocyte count <200 cells/mm 3 compared to single universal algorithm by WHO for regions with limited resources [22] .
The new examination should have relative advantages compared to currently available methods. BMI combined with complete blood count is cheap, simple, and does not require well trained technicians, may give rapid results and widely available in many regions. Therefore, combination of BMI, TLC, and hemoglobin level is used as surrogate marker for CD4 + lymphocyte count to initiate ARV treatment in regions with limited resources where those examinations are not readily available.
By using simple markers to initiate ARV treatment, we expected more patients with severe immunodeficiency will be detected and in the hope to be followed by decrease mortality rate. Study by Mekonnen et.al., demonstrated that by applying WHO guideline where TLC <1200 cells/mm 3 is single universal algorithm 41% patients died before treatment is began with ARV; meanwhile by using simple marker where combination of TLC and anemia was used as guide to initiate ARV treatment, 78% of the cohort would receive ARV and would decrease mortality rate in patients before receiving ARV treatment [23] .
Based on this study, in HIV infected patients combination of BMI <18.5 kg/m 2 , TLC <1200 cells/mm 3 and hemoglobin level <12.2 gr/dl in male and <11.2 gr/dl in female, ARV should be started immediately because the patients are in severe immunodeficiency state although clinically asymptomatic. This finding particularly has a role in HIV stage I and II (WHO) patients and widely validation through data from other studies with similar settings is needed.
Conclusion
Combination of BMI, TLC, and hemoglobin level is sensitive and accurate to predict severe immunodeficiency in HIV infected patients. This combination may also be applied as surrogate marker for CD4 + lymphocyte count in initiating ARV treatment in regions with limited resources where CD4 + lymphocyte count or viral load are not available.
Conflict of interest
There is no conflict of interests regarding the publication of this paper.
Ethical approval:
This study was exempted by the internal review boards of all participating institutions.
